SG Americas Securities’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $489K | Buy |
43,401
+26,050
| +150% | +$294K | ﹤0.01% | 1533 |
|
|
2025
Q1 | $175K | Buy |
+17,351
| New | +$175K | ﹤0.01% | 2345 |
|
|
2024
Q4 | – | Sell |
-29,925
| Closed | -$345K | – | 3064 |
|
|
2024
Q3 | $345K | Sell |
29,925
-14,712
| -33% | -$170K | ﹤0.01% | 1792 |
|
|
2024
Q2 | $472K | Buy |
+44,637
| New | +$472K | ﹤0.01% | 1560 |
|
|
2023
Q4 | – | Sell |
-9,999
| Closed | -$117K | – | 3012 |
|
|
2023
Q3 | $117K | Sell |
9,999
-75,632
| -88% | -$885K | ﹤0.01% | 2439 |
|
|
2023
Q2 | $863K | Sell |
85,631
-8,315
| -9% | -$83.8K | 0.01% | 1007 |
|
|
2023
Q1 | $693K | Buy |
93,946
+8,839
| +10% | +$65.2K | 0.01% | 1331 |
|
|
2022
Q4 | $680K | Buy |
+85,107
| New | +$680K | 0.01% | 1125 |
|